Increased Levels of Circulating Advanced Glycation End-Products in Menopausal Women with Osteoporosis
Background: Advanced glycation end-products (AGEs) can accumulate in organs and tissues during ageing and diabetes. Increased levels of AGEs are found in the bone tissue of patients with osteoporosis. The purpose of this study was to evaluate circulating AGEs in patients with osteoporosis.
Main Authors: | Yang, Deng-Ho, Chiang, Tsay-I, Chang, I-Chang, Lin, Fu-Huang, Wei, Cheng-Chung, Cheng, Ya-Wen |
---|---|
Format: | Online |
Language: | English |
Published: |
Ivyspring International Publisher
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970097/ |
Similar Items
-
Expression levels of estrogen receptor α mRNA in peripheral blood cells are an independent biomarker for postmenopausal osteoporosis☆
by: Chou, Chi-Wen, et al.
Published: (2016) -
Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
by: Sanguineti, Roberta, et al.
Published: (2014) -
The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
by: Ko, Shun-Yao, et al.
Published: (2015) -
Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol
by: Xu, Lei, et al.
Published: (2016) -
Commentary on guidelines on osteoporosis and menopause - Indian Menopause Society
by: Fenton, Anna
Published: (2013)